MAPLE GROVE, Minn.

明尼苏达州梅普尔格罗夫

,

，

Aug. 24, 2026

2026年8月24日

/PRNewswire/ -- RPC is pleased to announce the successful acquisition of the Peracidin

/美通社/ -- RPC 很高兴地宣布成功收购 Peracidin

®

®

product line from Angelini Pharma, expanding our portfolio of high-quality peroxyacetic/peracetic acid (PAA) sterilants for dialysis, water treatment and life science applications.

来自 Angelini Pharma 的产品线，扩充了我们用于透析、水处理和生命科学应用的高质量过氧乙酸/过乙酸（PAA）灭菌剂产品组合。

This strategic acquisition reinforces our long-term commitment to providing reliable and trusted industry-leading products, exceptional customer support, and uninterrupted supply to healthcare providers and distribution partners worldwide.

此次战略性收购进一步巩固了我们对全球医疗保健提供商和分销合作伙伴的长期承诺，即提供可靠、值得信赖的行业领先产品，卓越的客户服务以及不间断的供应保障。

'The acquisition of the Peracidin

过酸的获取

®

注册商标

product line represents an important milestone in RPC's continued growth and further strengthens our leadership in peracetic acid technologies and innovative dialysis solutions, while broadening our ability to serve customers across complementary healthcare and water treatment markets,' said Vern Taaffe, CEO.

“该产品线是RPC持续增长的重要里程碑，进一步巩固了我们在过氧乙酸技术和创新透析解决方案领域的领导地位，同时拓展了我们在互补的医疗保健和水处理市场服务客户的能力。”首席执行官Vern Taaffe表示。

'We are honored to welcome Peracidin.

我们很荣幸地欢迎 Peracidin。

®

®

customers to RPC and look forward to building on the product's strong legacy by providing exceptional service, reliable supply, and the quality all of our customers have come to expect.'

客户转向RPC，我们期待通过提供卓越的服务、可靠的供应以及所有客户一贯期望的高品质，在这一产品的深厚积淀之上再创佳绩。

For additional information about Peracidin® or Micro-X®, please contact RPC at

如需获取有关 Peracidin® 或 Micro-X® 的更多信息，请联系 RPC，联系方式如下：

[email protected]

[email protected]

, or call US: (800) 647-3873 or International: (520) 888-5550

，或致电美国：(800) 647-3873，国际电话：(520) 888-5550

About RPC

关于 RPC

RPC is a leading manufacturer and provider of innovative products, technical expertise, and specialized solutions for the dialysis industry, supporting healthcare providers and distribution partners worldwide. Drawing on decades of dialysis experience, RPC develops, manufactures, and supplies high-quality products that improve patient care and address the technical needs of dialysis providers.

RPC是透析行业领先的产品制造商和供应商，提供创新产品、专业技术及定制化解决方案，支持全球的医疗保健提供商和分销合作伙伴。凭借数十年的透析行业经验，RPC开发、制造并供应高质量产品，以改善患者护理并满足透析服务提供商的技术需求。

The company maintains an active commitment to advancing industry standards through participation in the Association for the Advancement of Medical Instrumentation (AAMI), including AAMI Corporate and Renal Disease and Detoxification (RDD) Committee membership, and its employees are active members of AAMI and the National Association of Nephrology Technicians/Technologists (NANT).

公司通过参与医疗仪器促进协会（AAMI），包括成为AAMI企业会员及肾脏疾病与解毒（RDD）委员会成员，持续积极致力于推动行业标准的发展；其员工也是AAMI和国家肾病技师/技术师协会（NANT）的活跃成员。

Headquartered in Tucson, Arizona, with additional offices and production in Maple Grove, MN, RPC serves customers and distribution partners worldwide with a comprehensive portfolio of products backed by technical expertise, responsive customer service, and a commitment to quality. For more information, visit .

RPC 总部位于亚利桑那州图森市，并在明尼苏达州梅普尔格罗夫设有额外的办事处和生产基地，凭借技术专长、响应迅速的客户服务以及对质量的承诺，通过全面的产品组合为全球客户和分销合作伙伴提供服务。欲了解更多信息，请访问 。

https://www.rpc-rabrenco.com

https://www.rpc-rabrenco.com

.

。

About Angelini Pharma

关于安吉里尼制药

Angelini Pharma is an international pharmaceutical company and part of Angelini Industries. The company researches, develops, and commercializes health solutions with a particular focus on Brain Health, including mental health and epilepsy, and the Consumer market. Founded in Italy at the beginning of the twentieth century, Angelini Pharma operates directly in 20 countries, employing more than 3,000 people.

安吉里尼制药（Angelini Pharma）是一家国际制药公司，隶属于安吉里尼工业集团（Angelini Industries）。该公司致力于健康解决方案的研发与商业化，特别聚焦于脑部健康（包括心理健康和癫痫）以及消费者市场。安吉里尼制药于20世纪初在意大利创立，目前在20个国家直接开展业务，员工人数超过3,000人。

Its products are commercialized in over 70 countries through strategic alliances with leading international pharmaceutical groups. For more information on Angelini Pharma, visit .

通过与领先国际制药集团的战略联盟，其产品已在70多个国家实现商业化。欲了解有关安杰里尼制药（Angelini Pharma）的更多信息，请访问。

https://www.angelinipharma.com

https://www.angelinipharma.com

.

。

Media Contact: Stuart Geller,

媒体联系人：斯图尔特·盖勒，

[email protected]

[email protected]

SOURCE RPC

源 RPC

21

二十一

%

%

more press release views with

更多新闻稿浏览量

Request a Demo

申请演示